Vaccinex Inc (VCNX)
5.537
-0.09
(-1.57%)
USD |
NASDAQ |
May 16, 16:00
5.30
-0.24
(-4.27%)
After-Hours: 20:00
Vaccinex Total Assets (Quarterly): 3.631M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.631M |
| September 30, 2023 | 2.558M |
| June 30, 2023 | 3.085M |
| March 31, 2023 | 4.895M |
| December 31, 2022 | 7.977M |
| September 30, 2022 | 8.612M |
| June 30, 2022 | 12.57M |
| March 31, 2022 | 18.12M |
| December 31, 2021 | 9.843M |
| September 30, 2021 | 15.19M |
| June 30, 2021 | 23.79M |
| March 31, 2021 | 30.68M |
| December 31, 2020 | 11.70M |
| Date | Value |
|---|---|
| September 30, 2020 | 18.72M |
| June 30, 2020 | 3.099M |
| March 31, 2020 | 4.881M |
| December 31, 2019 | 4.604M |
| September 30, 2019 | 10.81M |
| June 30, 2019 | 7.121M |
| March 31, 2019 | 13.29M |
| December 31, 2018 | 22.03M |
| September 30, 2018 | 29.88M |
| June 30, 2018 | 4.715M |
| March 31, 2018 | 4.946M |
| December 31, 2017 | 5.575M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.558M
Minimum
Sep 2023
30.68M
Maximum
Mar 2021
10.63M
Average
8.612M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 1.804B |
| Avinger Inc | 13.77M |
| RAPT Therapeutics Inc | 155.82M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 13.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.942M |
| Shareholders Equity (Quarterly) | -2.311M |